4//SEC Filing
Malier Vanessa 4
Accession 0001140361-21-037655
CIK 0001865494other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:16 PM ET
Size
14.5 KB
Accession
0001140361-21-037655
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Malier Vanessa
Director
Transactions
- Purchase
Common Stock
2021-11-09$14.00/sh+162,500$2,275,000→ 958,559 total(indirect: See footnote) - Purchase
Common Stock
2021-11-09$14.00/sh+162,500$2,275,000→ 430,477 total(indirect: See footnote) - Conversion
Common Stock
2021-11-09+267,977→ 267,977 total(indirect: See footnote) - Conversion
Common Stock
2021-11-09+796,059→ 796,059 total(indirect: See footnote) - Conversion
Series C Preferred Stock
2021-11-09−21,325→ 0 total(indirect: See footnote)→ Common Stock (267,977 underlying) - Conversion
Series C Preferred Stock
2021-11-09−63,350→ 0 total(indirect: See footnote)→ Common Stock (796,059 underlying)
Footnotes (3)
- [F1]Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date.
- [F2]The securities are held by Kurma Biofund III FPCI. Kurma Partners is the management company of Kurma Biofund III FPCI. The reporting person is a member of the board of directors of Kurma Partners, and may be deemed to share voting and investment power with respect to the shares beneficially owned by Kurma Biofund III FPCI and disclaims Section 16 beneficial ownership of such securities held by Kurma Biofund III FPCI, except to the extent of her pecuniary interest therein, if any.
- [F3]The securities are held by SKCI FPCI. Kurma Partners is the management company of SKCI FPCI. The reporting person is a member of the board of directors of Kurma Partners, and may be deemed to share voting and investment power with respect to the shares beneficially owned by SKCI FPCI and disclaims Section 16 beneficial ownership of such securities held by SKCI FPCI, except to the extent of her pecuniary interest therein, if any.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001891515
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:16 PM ET
- Size
- 14.5 KB